Sheila Grant

Sheila Grant is a declared insider of Cardiome Pharma Corp., with filings sourced from SEDI. Over a trading history stretching from 27 June 2016 to 28 March 2018, the count stands at 10 filings.

Both buying and selling appear: 2 purchases worth €16k, against 1 sale worth €11k. Netting one side against the other leaves €4,309 of net buying. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 7 option exercises. In 2018 alone, the filings show no purchases and 1 sale.

The newest entry dates from 2 April 2018: an option exercise, in Cardiome Pharma Corp. The most recent open-market purchase was published on 15 August 2016, 3,723 days ago. Between a trade and the moment it shows up on SEDI, the median delay is 3 days. That lag is the time during which only the insider knows about the trade. Source: insider filings from SEDI. Past trades are no guide to future returns.